COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,677 Articles (22,913 medRxiv, 8,764 bioRxiv)

Most recent first Previous |  Page 1747: Articles 17461-17470  | Next

Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection
Sandberg, J. T., Varnaite, R., Christ, W., Chen, P., Muvva, J. R., Maleki, K. T., Garcia, M., Dzidic, M., Folkesson, E., Skagerberg, M., Ahlen, G., Frelin, L., Sällberg, M., The Karolinska COVID-19 Study Group, , Eriksson, L. I., Rooyackers, O., Sönnerborg, A., Buggert, M., Björkström, N. K., Aleman, S., Stralin, K., Klingström, J., Ljunggren, H.-G., Blom, K., Gredmark-Russ, S.
10.1101/2021.03.17.435581 — Posted: 2021-03-17 Discussion: Onsite
SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway
Khan, S., Shafiei, M. S., Longoria, C., Schoggins, J., Savani, R. C., Zaki, H.
10.1101/2021.03.16.435700 — Posted: 2021-03-17
SARS-CoV-2 Spike receptor-binding domain with a G485R mutation in complex with human ACE2
Weekley, C. M., Purcell, D. F. J., Parker, M. W.
10.1101/2021.03.16.434488 — Posted: 2021-03-17
Identification of ACE2 mutations that modulate SARS-CoV-2 spike binding across multiple mammalian species
Heinzelman, P., Romero, P. A.
10.1101/2021.03.16.435705 — Posted: 2021-03-17
Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants
Ferrari, M., Mekkaoui, L., Ilca, F. T., Akbar, Z., Bughda, R., Lamb, K., Ward, K., Parekh, F., Karattil, R., Allen, C., Wu, P., Baldan, V., Mattiuzzo, G., Bentley, E. M., Takeuchi, Y., Sillibourne, J., Datta, P., Kinna, A., Pule, M., Onuoha, S.
10.1101/2021.03.17.435802 — Posted: 2021-03-17
Show us the Data: Global COVID-19 Wastewater Monitoring Efforts, Equity, and Gaps
Naughton, C. C., Roman, F. A., Alvarado, A. G. F., Tariqi, A. Q., Deeming, M. A., Bibby, K., Bivins, A., Rose, J. B., Medema, G., Ahmed, W., Katsivelis, P., Allan, V., Sinclair, R., Zhang, Y., Kinyua, M. N.
10.1101/2021.03.14.21253564 — Posted: 2021-03-17
In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2.
ElZein, R., Abdel Sater, f., Fakhreddine, S., Abi Hanna, P., Feghali, R., Hamad, H., Ayoub, F.
10.1101/2021.03.07.21252302 — Posted: 2021-03-17
Knowledge barriers in the symptomatic-COVID-19 testing programme in the UK: an observational study
Graham, M. S., May, A., Varsavsky, T., Sudre, C., Murray, B., Klaser, K., Antonelli, M., Canas, L., Molteni, E., Modat, M., Drew, D. A., Nguyen, L., Rader, B., Hu, C., Capdevila, J., Hammers, A., Chan, A., Wolf, J., Brownstein, J., Spector, T., Ourselin, S., Steves, C., Astley, C.
10.1101/2021.03.16.21253719 — Posted: 2021-03-17
High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study
Das, A., Weaver, L., Saffaran, S., Yehya, N., Scott, T. E., Chikhani, M., Laffey, J. G., Hardman, J. G., Camporota, L., Bates, D.
10.1101/2021.03.17.21253788 — Posted: 2021-03-17
THE EFFECTIVENESS OF ACB-IP 1.0 UNIVERSAL PATHOGEN FREE CONCENTRATED COCKTAIL CONVALESCENT PLASMA IN COVID-19 INFECTION
Hemsinlioglu, C., Pelit, N. B., Yalcin, K., Gunaydin, O. S., Ozturk Sahin, N., Savas Karagacli, E., Elibol, O., Demir, S. O., Safak, E., Turan, R. D., Celebi, G., Kocaoglu, M. E., Sir Karakus, G., Yurtsever, B., Tastan, C., Abanuz, S., Cakirsoy, D., Dilek Kancagi, D., Torun, Z., Seyis, U., Elek, M., Zengin, R., Kocagoz, A. S., Cuhadaroglu, C., Birgen, N., Ratip, S., Ovali, E.
10.1101/2021.03.05.21251413 — Posted: 2021-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).